Use of an inhibitor of CSF-1 activity for the treatment of inflammatory bowel disease

Details for Australian Patent Application No. 2004289098 (hide)

International Classifications

Event Publications

25 May 2006 PCT application entered the National Phase

PCT publication WO2005/046657 Priority application(s): WO2005/046657

14 February 2008 Assignment before Grant

Celltech R&D Limited The application has been assigned to UCB Pharma S.A.

1 July 2010 Application Accepted

Published as AU-B-2004289098

28 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.